Literature DB >> 22403417

Multicytokine detection improves latent tuberculosis diagnosis in health care workers.

Pierre-Alain Rubbo1, Nicolas Nagot, Vincent Le Moing, Marylène Brabet, Arnaud Bourdin, Erika Nogué, Karine Bolloré, Jean-Pierre Vendrell, Philippe Van De Perre, Edouard Tuaillon.   

Abstract

In a low-incidence setting, health care workers (HCW) are at a higher risk of tuberculosis than the general population. The suboptimal sensitivity of the QuantiFERON-TB Gold In-Tube (QFT) test remains a critical issue when identifying occupational latent tuberculosis infection (LTBI) in HCW. The aim of this study was to identify additional biomarkers in order to overcome the limits of gamma interferon (IFN-γ) release assays (IGRAs) and improve the performance of LTBI diagnosis within this population. Seventy Bacille Calmette-Guérin-vaccinated HCW regularly exposed to Mycobacterium tuberculosis were grouped according to QFT results into an LTBI-positive group (positive QFT, n = 8), an LTBI-negative group (normal QFT and negative tuberculin skin test [TST], n = 21), and an undetermined group (subpositive QFT and/or positive TST, n = 41). The secretion of 22 cytokines in response to QFT-specific stimulation was quantified using a multiparameter-based immunoassay. As a result, thresholds discriminating LTBI-positive from LTBI-negative HCW were established by comparing areas under the receiver operating characteristic curves for interleukin-2 (IL-2), IL-15, IFN-γ-induced protein 10 (IP-10), and the monokine induced by IFN-γ (MIG), which are biomarkers differentially secreted by the two groups. The combination of IL-15 and MIG provided a sensitivity of 100% and a specificity of 94.1% in distinguishing LTBI-positive from LTBI-negative HCW. When using IL-15 and MIG among the undetermined group, 6/45 HCW could be classified in the LTBI-positive group. The use of additional biomarkers after IGRA screening could improve the diagnosis of LTBI. The performance of these biomarkers and their use in combination with TST and/or QFT, as well as the cost-effectiveness of such a diagnostic strategy, should be evaluated in further larger clinical trials.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403417      PMCID: PMC3347142          DOI: 10.1128/JCM.00117-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review.

Authors:  Alice Zwerling; Susan van den Hof; Jerod Scholten; Frank Cobelens; Dick Menzies; Madhukar Pai
Journal:  Thorax       Date:  2011-01-12       Impact factor: 9.139

2.  Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis.

Authors:  Simon J Tsiouris; David Coetzee; Patricia L Toro; Judy Austin; Zena Stein; Wafaa El-Sadr
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.

Authors:  A Sauty; M Dziejman; R A Taha; A S Iarossi; K Neote; E A Garcia-Zepeda; Q Hamid; A D Luster
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

4.  Serial testing of health care workers for tuberculosis using interferon-gamma assay.

Authors:  Madhukar Pai; Rajnish Joshi; Sandeep Dogra; Deepak K Mendiratta; Pratibha Narang; Shriprakash Kalantri; Arthur L Reingold; John M Colford; Lee W Riley; Dick Menzies
Journal:  Am J Respir Crit Care Med       Date:  2006-05-11       Impact factor: 21.405

Review 5.  Specific immune-based diagnosis of tuberculosis.

Authors:  P Andersen; M E Munk; J M Pollock; T M Doherty
Journal:  Lancet       Date:  2000-09-23       Impact factor: 79.321

6.  Monokine induced by interferon gamma and IFN-gamma response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients.

Authors:  Clarice Abramo; Krista E Meijgaarden; Daniely Garcia; Kees L M C Franken; Michèl R Klein; Arend J Kolk; Sérgio C Oliveira; Tom H M Ottenhoff; Henrique C Teixeira
Journal:  Microbes Infect       Date:  2005-07-22       Impact factor: 2.700

Review 7.  Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.

Authors:  Madhukar Pai; Alice Zwerling; Dick Menzies
Journal:  Ann Intern Med       Date:  2008-06-30       Impact factor: 25.391

Review 8.  Risk of tuberculosis infection and disease associated with work in health care settings.

Authors:  D Menzies; R Joshi; M Pai
Journal:  Int J Tuberc Lung Dis       Date:  2007-06       Impact factor: 2.373

Review 9.  Tuberculosis among health-care workers in low- and middle-income countries: a systematic review.

Authors:  Rajnish Joshi; Arthur L Reingold; Dick Menzies; Madhukar Pai
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069

10.  Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.

Authors:  Morten Ruhwald; Janne Petersen; Kristian Kofoed; Hiroshi Nakaoka; Luis Eduardo Cuevas; Lovett Lawson; Stephen Bertil Squire; Jesper Eugen-Olsen; Pernille Ravn
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

View more
  17 in total

Review 1.  Diagnostic accuracy of IL-2 for the diagnosis of latent tuberculosis: a systematic review and meta-analysis.

Authors:  S Mamishi; B Pourakbari; M Teymuri; P-A Rubbo; E Tuaillon; A A Keshtkar; S Mahmoudi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-04       Impact factor: 3.267

2.  Is interleukin-2 an optimal marker for diagnosing tuberculosis infection? A systematic review and meta-analysis.

Authors:  Xia Qiu; Huiqing Wang; Ying Tang; Xiaojuan Su; Long Ge; Yi Qu; Dezhi Mu
Journal:  Ann Med       Date:  2020-07-30       Impact factor: 4.709

3.  IP-10 and MIG are compartmentalized at the site of disease during pleural and meningeal tuberculosis and are decreased after antituberculosis treatment.

Authors:  Qianting Yang; Yi Cai; Wei Zhao; Fan Wu; Mingxia Zhang; Kai Luo; Yan Zhang; Haiying Liu; Boping Zhou; Hardy Kornfeld; Xinchun Chen
Journal:  Clin Vaccine Immunol       Date:  2014-10-01

4.  IGRA-positive patients and interferon-gamma/interleukin-2 signatures: can the Fluorospot assay provide further information?

Authors:  P Bittel; D Mayor; P Iseli; T Bodmer; F Suter-Riniker
Journal:  Infection       Date:  2014-01-30       Impact factor: 3.553

5.  Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family.

Authors:  Babak Pourakbari; Setareh Mamishi; Majid Marjani; Mehrnaz Rasulinejad; Sabrina Mariotti; Shima Mahmoudi
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

6.  Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area.

Authors:  Novel N Chegou; Paulin N Essone; Andre G Loxton; Kim Stanley; Gillian F Black; Gian D van der Spuy; Paul D van Helden; Kees L Franken; Shreemanta K Parida; Michel R Klein; Stefan H E Kaufmann; Tom H M Ottenhoff; Gerhard Walzl
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

7.  Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting.

Authors:  Novel N Chegou; Anne K Detjen; Lani Thiart; Elisabetta Walters; Anna M Mandalakas; Anneke C Hesseling; Gerhard Walzl
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

8.  Early specific host response associated with starting effective tuberculosis treatment in an infection controlled placebo controlled mouse study.

Authors:  Alice L den Hertog; Alex F de Vos; Paul R Klatser; Richard M Anthony
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

9.  Interferon Gamma Release Assay versus Tuberculin Skin Testing among Healthcare Workers of Highly Diverse Origin in a Moderate Tuberculosis Burden Country.

Authors:  Sahal Al Hajoj; Bright Varghese; Alria Datijan; Mohammed Shoukri; Ali Alzahrani; Abdallah Alkhenizan; Abdulaziz AlSaif; Sahar Althawadi; Grace Fernandez; Abdulrahman Alrajhi
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

10.  High IFN-γ Release and Impaired Capacity of Multi-Cytokine Secretion in IGRA Supernatants Are Associated with Active Tuberculosis.

Authors:  Séverine Carrère-Kremer; Pierre-Alain Rubbo; Amandine Pisoni; Sophie Bendriss; Grégory Marin; Marianne Peries; Karine Bolloré; Dominique Terru; Sylvain Godreuil; Arnaud Bourdin; Philippe Van de Perre; Edouard Tuaillon
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.